In a remarkable milestone for innovation in India’s academic landscape, the Indian Institute of Technology (IIT) Madras has filed an unprecedented 417 patents during the financial year 2024–25. The announcement marks a historic achievement for IIT Madras, reaffirming its position as a national leader in research-driven technological innovation and intellectual property (IP) creation. Vision Turned […]
The rapid ascent of artificial intelligence (AI) is not only transforming industries but is also reshaping the intellectual property landscape. Recent data reveals that more than 86,000 AI-related patents have been filed globally between 2010 and 2025, marking a dramatic surge in innovation and investment in the field. These AI patents now account for over
Ola Group, which operates across ride-hailing, electric mobility, and artificial intelligence, has emerged as a technological frontrunner among India’s startups. The company now holds more than 50% of all patents filed by India’s 117 unicorns, according to data from the Indian Patent Advanced Search (IPAS) System. Collectively, Indian unicorns have filed just 229 patents—highlighting a
Heimdal, a leading European cybersecurity firm, has been awarded U.S. Patent No. 18333620 for a proprietary method that predicts the likelihood of a domain being malicious. The patented technology, titled “Apparatus and Method of Predicting Malicious Domains,” marks a significant step forward in Heimdal’s mission to redefine DNS security. This invention forms the foundation of
South Korea’s SK bioscience, the biopharmaceutical subsidiary of SK Group, announced on Wednesday that it has secured a decisive win in a patent dispute against U.S.-based biotechnology company Moderna, known globally for its development of mRNA COVID-19 vaccines. The legal challenge, initiated in 2023, contested Moderna’s South Korean patent concerning the use and modification of
Safe Pro Group Inc. (NASDAQ: SPAI), a leading provider of AI-driven defense and security technologies with a market capitalization of $37.32 million, announced the successful completion of national phase patent filings across nearly 50 international jurisdictions. This strategic move aims to secure global protection for the company’s proprietary technology that detects small-scale lethal threats—such as
ToolGen, Inc. (KOSDAQ: 199800), a biotechnology firm at the forefront of genome editing innovations, has filed a patent infringement lawsuit in the United Kingdom against Vertex Pharmaceuticals and its key manufacturing partners, Lonza and RoslinCT. The legal action centers on Vertex’s approved CRISPR-based gene therapy, CASGEVY, which ToolGen alleges utilizes its proprietary technology without proper
In a decisive move aimed at improving efficiency and safeguarding the integrity of the U.S. intellectual property system, the United States Patent and Trademark Office (USPTO) has announced the suspension of expedited examination for design patent applications, effective April 17, 2025. The policy change was officially detailed in a notice published in the USPTO’s Official
In a move designed to bridge the gap between pharmaceutical research and market success, a newly released guide is offering strategic advice to drug developers on how to craft more effective patent applications. Published on the widely respected platform DrugPatentWatch, the guide is titled “Drafting Effective Drug Patent Applications: Turning Science into Market Power” and
The case, centered on Roche’s high-priced drug risdiplam used to treat Spinal Muscular Atrophy (SMA), brought public health and drug affordability to the forefront of the legal discourse. Justice Mini Pushkarna, delivering the verdict on March 24, underscored the primacy of public health in patent litigation involving critical medications. “Public health is not something that
